Publications
160
Citations
1,460
Est. group size
~3
Recurring co-author estimate
Active years
61
Publishing since 1966
O. Hall's research focuses on opioid use disorder, particularly how chronic pain and stigma affect treatment access and outcomes. This work includes studies on primary care providers' willingness to prescribe medications like buprenorphine, the relationship between chronic pain conditions (such as fibromyalgia) and addiction relapse, and health disparities in overdose response and telehealth access. A prospective student might work on projects combining clinical epidemiology, survey-based research, and genetic/genomic data (e.g., genome-wide association studies) to understand and address substance use disorders.
Publication output has grown substantially over the last decade, rising from about 1-5 papers per year before 2022 to 10-14 papers per year from 2023 onward.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Genome-Wide Association Studies and Deep-Learning Functional Annotation of Opioid Use Disorder across Three Ancestries in the All of Us Research Program
medRxiv · 2026
- Different forms of stigma and rural primary care professionals' willingness to prescribe buprenorphine
Journal of Substance Use and Addiction Treatment · 2025
- Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process
JAMA Network Open · 2025
- Clinical Characteristics of Patients With and Without Chronic Pain Seeking Behavioral Health Treatment for Co-Occurring Opioid Use and Mental Health Disorders
Substance Use & Addiction Journal · 2025
- Withdrawal Interference Scale
PsycTESTS Dataset · 2025
- Sociodemographic Determinants of Telehealth Visits: A Comparison of Mental Health and Substance Use Disorders with Other Services
Epidemiologia · 2025
- Chronic overlapping pain conditions in individuals with active opioid use disorder: a descriptive study of syringe program participants
Journal of Addictive Diseases · 2025
- Health Care Professional Willingness to Treat Opioid Use Disorder vs Type 2 Diabetes in Primary Care
JAMA Network Open · 2025
- Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
Addiction Science & Clinical Practice · 2024
- Who feels safe calling 911: are prior experiences of anti-Black racial discrimination associated with hesitancy seeking emergency medical services in the event of accidental drug overdose? – a study protocol
Annals of Medicine · 2024
- Withdrawal interference scale: a novel measure of withdrawal-related life disruption in opioid use disorder and alcohol use disorder
The American Journal of Drug and Alcohol Abuse · 2024
- Fibromyalgia is associated with increased odds of prior pain-precipitated relapse among non-treatment-seeking individuals with opioid use disorder
Annals of Medicine · 2024
- Untreated Opioid Use Disorder and Health-Related Quality of Life Among Syringe Service Program Clients
JAMA Network Open · 2024
- Case report: Successful induction of buprenorphine in medically complex patients concurrently on opioids: a case series at a tertiary care center
Frontiers in Pharmacology · 2024
- Pain and its Perceived Relatedness to the Onset, Maintenance, and Relapse of Opioid use Disorder: A Descriptive Study of Non-Treatment-Seeking Individuals
Canadian Journal of Pain · 2024
- JAMA Network Open×5
- Journal of Addictive Diseases×4
- JAMA Pediatrics×3
- Annals of Medicine×3
- American Journal of Obstetrics and Gynecology×3
- Bjorn Kluwe
Medicine · The Ohio State University
- Jeffrey Patrick
Medicine · The Ohio State University
- Mark R. Kelley
Medicine · Indiana University
- Erin R. McKnight
Medicine · The Ohio State University
- Aimee Mack
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile